Pure Global
NCT05998226

VAT-2: Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions in Nursing Homes

Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions From Clinicians in Nursing Homes: A Multicenter Randomised Controlled Trial
Public Health Service of Amsterdam·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bacterial Infections
Drug/Device/Intervention
Virtual Antimicrobial stewardship Team (VAT)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Public Health Service of Amsterdam
Location
Amsterdam, Netherlands
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2023
End date
Jun 30, 2024
Enrollment
54 participants
Primary outcome

Inappropriate antibiotic prescriptions

Summary

The Virtual Antimicrobial stewardship Team (VAT) study aims to evaluate, in a randomized
 controlled trial (RCT), the effect of a weekly virtual antimicrobial stewardship (AMS)
 intervention on the appropriateness of prescribing antibiotics for nursing home (NH)
 residents with urinary tract infections (UTI), respiratory tract infections (RTI) or skin and
 soft tissue infections (SSTI) compared to standard care for NH residents in Dutch NHs in the
 provinces of North-Holland and Flevoland. The secondary aim is to identify barriers and
 facilitators to implement a stewardship intervention and subsequently develop an
 implementation guide.

ICD-10 classifications
Bacterial infection, unspecifiedBacterial, viral and other infectious agentsOther bacterial intestinal infectionsOther bacterial diseasesOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05998226
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05998226 through Pure Global AI's free database. This phase not specified trial is sponsored by Public Health Service of Amsterdam and is currently Recruiting. The study focuses on Bacterial Infections. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.